Genomma Lab USA
Genomma Lab USA is a Houston-based, wholly-owned US subsidiary of Mexican publicly listed Genomma Lab Internacional, commercializing 17 mass-market OTC and personal-care brands — including Cicatricure, Tío Nacho, SueroX, Bufferin, and Tukol — to US Hispanic and Latin American consumers through drugstores, supermarkets, and e-commerce.
- Company typePrivate
- Founded1996
- HeadquartersHouston, United States
- Headcount1,001–5,000
- GTM typeB2C
- OfferingHardware or Manufacturing
What Genomma Lab USA does
Genomma Lab USA, INC. is the Houston, Texas-based United States subsidiary of Mexican publicly listed pharmaceutical and personal-care products company Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB). The US entity commercializes a portfolio of 17 mass-market OTC pharmaceutical, personal care, skincare, hair care, hydration, and dermocosmetic sub-brands — including Cicatricure, Tío Nacho, SueroX, Asepxia, Bufferin, Bio-Electro, Xray, Tukol, Medicasp, Silka, Goicoechea, Nikzon, Lagicam, Shot-B, Teatrical, Vanart, and Pomada Dragon — primarily targeting US Hispanic and Latin American mass-market consumers via drugstores, supermarkets, and e-commerce. Genomma Lab USA, INC. does not appear to operate its own manufacturing; production is centralized at the parent's EDGE-certified Toluca, Mexico plant with cogeneration energy infrastructure, LED lighting systems, ECOPLAS-certified recyclable polyethylene packaging, and US freight handled via SmartWay-certified carriers.
The business model is B2C/B2B2C unit-pricing revenue from branded consumer packaged goods sold through mass-market retailers and pharmacy chains, with no disclosed subscription or enterprise tier. Channel relationships are reinforced by the GEN Expertos pharmacist loyalty/education program, while grassroots brand advocacy is built through sustained NGO alliances (Operación Sonrisa, Direct Relief, CADENA, Medical Impact) and ESG certifications (DJSI, MSCI ESG, ESR, EDGE, WEPs, EquidadMX, EquidadAR, CDP). The company is privately held as a wholly-owned operating subsidiary of a Mexican parent that reports $1B+ group revenue across 18+ countries; the US subsidiary's standalone revenue is not separately disclosed. In July 2024, the parent invested US$25.6 million to acquire four additional brands (Suero Repone, Suero Oral, IBU 400, Treg) generating USD$21.7 million in trailing-12-month sales, extending the US portfolio in oral rehydration, ibuprofen analgesia, and allergy categories.
Genomma Lab USA firmographics
Firmographics- Name
- Genomma Lab USA
- Legal name
- Genomma Lab USA, INC.
- Website
- https://genommalab.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Genomma Lab USA is a Houston-based, wholly-owned US subsidiary of Mexican publicly listed Genomma Lab Internacional, commercializing 17 mass-market OTC and personal-care brands — including Cicatricure, Tío Nacho, SueroX, Bufferin, and Tukol — to US Hispanic and Latin American consumers through drugstores, supermarkets, and e-commerce.
- Ownership category
- akta.pro rank
Genomma Lab USA industry classification
Industry- Product category
- Consumer Pharmaceuticals and Personal Care
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
- akta.pro secondary industries
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Mass Beauty & Drugstore Beauty Distribution (CRAOAEAA)
Keywords
Where Genomma Lab USA is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices19 records
Markets served
Genomma Lab USA business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
Revenue model
- OTC pharmaceutical and personal care product sales: Primary revenue stream: sales of over-the-counter (OTC) pharmaceuticals (e.g., Lomecan, XL3, Novamil), personal care (Cicatricure, Tío Nacho, Nikzon), and wellness (SueroX, Alliviax) brands through mass-market retailers, pharmacy chains, and e-commerce across 18+ countries. Pricing per unit/SKU via retail and wholesale channels.
- Brand portfolio acquisitions and product line growth: Strategic growth via acquisitions of consumer health brands; example: US$25.6M deal to acquire four brands generating USD$21.7M in trailing-12-month sales, expanding revenue base.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | — | Per-SKU retail pricing across drugstores, supermarkets, and e-commerce |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels6 records
Genomma Lab USA product offering
Product offeringCore offering
Genomma Lab USA markets and distributes a diversified portfolio of over-the-counter (OTC) pharmaceutical, personal care, skincare, hair care, hydration, and dermocosmetic consumer brands — including Suerox, Alliviax, Cicatricure, XL3, Tío Nacho, Nikzon, Lomecan, Novamil, Asepxia, Bufferin, Bio-Electro, Silka, Tukol, Vanart and others — through mass-market drugstores, supermarket chains, pharmacy wholesalers, and e-commerce channels serving the US Hispanic market and consumers across 18+ countries in the Americas.
Product overview
Genomma Lab USA is not a unified software platform but a multi-brand consumer packaged goods business unit: a portfolio of independent OTC pharmaceutical, personal care, skincare, hair care, hydration, and dermocosmetic sub-brands commercialized under the Genomma Lab USA umbrella. The portfolio comprises distinct sub-brands including the analgesic Bufferin, Bio-Electro, Pomada Dragon and Xray (joint care); the skincare lines Cicatricure, Asepxia, and Teatrical; the hair care brands Tío Nacho, Vanart, and Medicasp; the hydration brand Suerox; intimate-health and hemorrhoid brands Lagicam and Nikzon; foot care brand Silka; leg-care brand Goicoechea; cough brand Tukol; and the nutraceutical Shot-B. Each brand operates as an independent consumer product line with its own positioning, formulation, and target segment, but they are united under the parent company's manufacturing, distribution, and regulatory infrastructure in the US.
Differentiator
Problem solved
Functional benefit
Brands
- Asepxia: Skincare brand for acne and imperfections; sold in US market via asepxia.us
- Bio-Electro
- Bufferin
- Cicatricure
- Pomada Dragon
- Goicoechea
- Lagicam
- Medicasp
- Nikzon
- Shot-B
- Silka
- Suerox
- Teatrical
- Tío Nacho
- Tukol
- Vanart
- X-Ray
Products and services
- Asepxia Skincare line focused on treating and reducing skin blemishes and imperfections for mass-market consumers.
- Bio-Electro OTC analgesic brand positioned for migraine and tension headache relief.
- Bufferin Pain relief medication (analgesic) marketed within Genomma Lab USA's OTC portfolio.
- Cicatricure Skincare brand focused on scar care, skin regeneration, and anti-aging treatments.
- Pomada Dragon Topical analgesic ointment used for back pain and muscle-related aches.
- Goicoechea Dermocosmetic brand focused on leg care, particularly varicose veins and heavy-leg sensations.
- Lagicam Intimate health brand addressing feminine hygiene and care needs.
- Medicasp Anti-dandruff shampoo and scalp care brand.
- Nikzon OTC brand addressing hemorrhoid symptoms and related anorectal discomfort.
- Shot-B Nutraceutical/energy brand positioned around performance, energy, and productivity in shot-format supplements.
- Silka Foot care brand addressing athlete's foot and related fungal/dermatological conditions.
- Suerox Oral rehydration solution brand offering electrolyte/hydration beverages and serum-style products.
- Teatrical Skincare brand developed with a theatrical/cinema heritage, positioned in the premium skincare segment.
- Tío Nacho Hair care brand offering shampoos and treatments aimed at hair strengthening and anti-hair-loss.
- Tukol OTC brand addressing cough and respiratory congestion symptoms.
- Vanart Hair care brand offering shampoo and treatment lines.
- Xray OTC brand focused on joint pain relief and mobility support.
Quantifiable outcome
- US$25.6M acquisition of four brands generating USD$21.7M trailing-12-month sales
- +2 more outcomes
Companies that use Genomma Lab USA
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Genomma Lab USA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Genomma Lab USA partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core and minor.
- UBEEScoreCo-development partner for the Tío Nacho Bee-Lab initiative in the United States, Colombia, and Costa Rica, combining bee-derived ingredients with Genomma Lab's hair-care brand.
- Direct Relief MéxicocoreHumanitarian alliance for the donation of medical and personal-care products to vulnerable communities across Latin America.
- Operación Sonrisa (Operation Smile)coreLong-standing alliance across Latin America supporting cleft-palate surgeries through product donations and volunteer engagement.
- CADENAminorNGO partner for humanitarian response in Estado de México wildfires (product donations to affected communities).
- Medical ImpactminorNGO partner for humanitarian response to Hurricane Otis in Guerrero, Mexico (medical product donations).
- World Central KitchenminorNGO partner for humanitarian response to Hurricane Otis in Guerrero, Mexico (food and relief support).
- Farmacias AhumadaminorChilean pharmacy chain partner for product donations supporting communities affected by the central Chile fires.
- Fundación OrigenminorNGO partner for humanitarian response to Hurricane Otis in Guerrero, Mexico (product donations).
- Soriana FundaciónminorFoundation partner of Organización Soriana supporting Hurricane Otis relief efforts with product donations.
- Gilberto A.C.minorNGO partner for humanitarian response to Hurricane Otis in Guerrero, Mexico (product donations).
- Fundación Pro Mazahua (Pro México Indígena)minorNGO partner supporting indigenous communities in Mexico (Mazahua region) through product donations and community programs.
- SmartWaycoreUS Environmental Protection Agency (EPA) SmartWay program partnership for measuring, benchmarking, and improving fuel efficiency and emissions across Genomma Lab USA's freight and logistics operations.
- ECOPLASminorIndustry scheme partner providing the ECOPLAS certificate for use of recyclable polyethylene in product packaging.
- SINGREMminorMexican industry program for the environmentally responsible disposal of expired medications; Genomma Lab participates as a member company.
- CANIPEC (GEECI)minorMembership in the Cámara Nacional de la Industria de Productos Cosméticos (CANIPEC) — specifically the GEECI self-regulation group for the cosmetics industry in Mexico.
- International Finance Corporation (IFC)coreParticipation in the IFC's Empresas Mexicanas por la Equidad (EM-X) program supporting gender equity and inclusion in Mexican companies.
- UN Global Compact / UN Women (WEPs)coreAdherence to the UN Women's Empowerment Principles (WEPs) signaling commitment to gender equality in business, workplace, marketplace, and community.
- Bolsa Mexicana de Valores (BMV)minorParticipation in the BMV's listed-issuer Sustainability Commission as a publicly traded Mexican company.
- Human Rights Campaign (HRC Equidad)minorAdherence to the HRC Equidad MX (Mexico) and Equidad AR (Argentina) LGBTQ+ workplace inclusion certifications.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Genomma Lab USA competitors and assessment
Company assessmentDirect peers
- Kenvue: Consumer health spinoff of Johnson & Johnson (Tylenol, Neutrogena, Zyrtec, Band-Aid) — comparable mass-market OTC/personal-care brand portfolio and US retail distribution model.
- Church & Dwight: Multi-brand consumer health and personal care company (Arm & Hammer, Batiste, Trojan, First Response) with a multi-category mass-market portfolio and proven M&A playbook — strongly comparable to Genomma's brand-acquisition strategy.
- Bayer Consumer Health: Global OTC and personal care division (Aspirin, Aleve, Claritin, Coppertone) with strong Latin American presence — directly comparable to Genomma Lab's OTC categories and regional footprint.
- Prestige Consumer Healthcare: Multi-brand OTC and consumer healthcare company (BC/Goody's, Monistat, DenTek, Clear Eyes) selling through mass-market retailers — closely mirrors Genomma Lab's portfolio strategy of acquiring and operating diverse OTC/personal-care brands in the US.
- Perrigo Company: Global OTC and self-care products company with strong store-brand and branded OTC presence across analgesics, cough/cold, dermatology, and personal care — directly comparable to Genomma's OTC mass-market positioning.
- Haleon: Consumer healthcare spinoff of GSK (Advil, Centrum, Sensodyne, Voltaren) operating global OTC, oral care, and wellness brands — directly comparable scale and category overlap with Genomma's OTC portfolio.
Broad incumbents
- Energizer Holdings: Personal care and household products company (Schick, Banana Boat, Playtex) — comparable mass-market personal care strategy and US/LATAM retail distribution model.
- Henkel: Global consumer and industrial products company (Schwarzkopf, Dial, Fa) with strong personal care and LATAM presence — broader portfolio but overlapping categories with Genomma's hair, skin, and personal care brands.
- Procter & Gamble: Global CPG giant with overlapping personal care and OTC categories (Vicks, Pepto-Bismol, Gillette, Head & Shoulders) — broader portfolio but competes directly with several Genomma brands on US shelves.
- Colgate-Palmolive: Global personal care and oral care major (Colgate, Palmolive, Softsoap) with strong Latin American presence — broader portfolio but comparable mass-market distribution and LATAM market participation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Genomma Lab USA social profiles
Digital presenceGenomma Lab USA compliance and trust
Trust signalCompliance6 records
Genomma Lab USA financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genomma Lab USA leadership team
Management profileNumber of profiles
Profiles3 records
Genomma Lab USA subsidiaries and ownership
Company hierarchySubsidiaries17 records
Genomma Lab USA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genomma Lab USA M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genomma Lab USA
What does Genomma Lab USA do?
Genomma Lab USA markets and distributes a diversified portfolio of over-the-counter (OTC) pharmaceutical, personal care, skincare, hair care, hydration, and dermocosmetic consumer brands — including Suerox, Alliviax, Cicatricure, XL3, Tío Nacho, Nikzon, Lomecan, Novamil, Asepxia, Bufferin, Bio-Electro, Silka, Tukol, Vanart and others — through mass-market drugstores, supermarket chains, pharmacy wholesalers, and e-commerce channels serving the US Hispanic market and consumers across 18+ countries in the Americas.
Is Genomma Lab USA a public or private company?
Genomma Lab USA is a private company. It is classified as corporate owned and is currently operating.
When was Genomma Lab USA founded?
Genomma Lab USA was founded in 1996. It employs 1,001 to 5,000 people.
Where is Genomma Lab USA based?
Genomma Lab USA is headquartered in Houston, United States, in the North America region.
How does Genomma Lab USA make money?
Two revenue lines are on record. OTC pharmaceutical and personal care product sales are the primary driver. The others are brand portfolio acquisitions and product line growth.
Who are Genomma Lab USA's main competitors?
Direct peers on record are Kenvue, Church & Dwight, Bayer Consumer Health, Prestige Consumer Healthcare, Perrigo Company and Haleon. Broad incumbents are Energizer Holdings, Henkel, Procter & Gamble and Colgate-Palmolive.
Does Genomma Lab USA have an API?
No public API is recorded for Genomma Lab USA.
What industry is Genomma Lab USA in?
Genomma Lab USA's product category is Consumer Pharmaceuticals and Personal Care. Its primary akta.pro industry code is CRAOAHAB, OTC Medicines & Consumer Health Products Distribution, with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 325412 and its SIC code is 2834.